HOWL Earnings

Quarterly EPS
$-0.38
Q3 2024
$-0.46
Q4 2024
$-0.40
Q1 2025
$-0.40
Q2 2025
$-0.36
Q3 2025
$-0.17
Q4 2025
$-0.28
Q1 2026
$0.08
Q2 2026
Latest Revenue21.0M
Latest Net Income3.7M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026$0.0821.0M3.7M+120.0%
Q1 2026-$0.280-13532000+30.0%
Q4 2025-$0.170-8381000+63.0%
Q3 2025-$0.360-16370000+5.3%
Q2 2025-$0.400-17982000-100.0%+0.0%
Q1 2025-$0.400-18089000-100.0%-2.6%
Q4 2024-$0.460-20400000-100.0%-39.4%
Q3 2024-$0.380-16673000-100.0%-65.2%
Q2 2024-$0.401.1M-17249000
Q1 2024-$0.39742.0K-16193000
Q4 2023-$0.331.5M-12003000
Q3 2023-$0.235.9M-8285000
Werewolf Therapeutics (HOWL) — Earnings